With more than 70,000 uses worldwide and policy endorsements for its use (JAMA Article), the Mayo Clinic Statin Choice Decision-Aid tool is helping patients and their clinicians have meaningful conversations about whether or not to use statins to reduce cardiovascular risk.
Discovery’s Edge, Mayo Clinic’s research magazine, recently highlighted how new tests are developed in Mayo Clinic’s Neuroimmunology Laboratory.
In this month’s “Hot Topic,” Bobbi Pritt, M.D., will discuss a powerful new technology called “multiplex molecular testing” that can assist in the diagnosis of gastrointestinal infections.
Ann Moyer, M.D., Ph.D., discusses an additional gene, NUDT15, which is important in the prediction of thiopurine-related toxicity This gene has been added to our TPMT genotyping assay available through Mayo Medical Laboratories.
In this month’s “Hot Topic,” Matt Binnicker, Ph.D., explains how syndromic testing can be used to diagnose viral and bacterial respiratory infections, the advantages of using this method, and when a syndromic respiratory panel should be ordered.